Acinetobacter baumannii at a Tertiary-Care Teaching Hospital in Jerusalem, Israel

AUTOR(ES)

Simhon, A.

FONTE

American Society for Microbiology

RESUMO

In a retrospective 10-year analysis of 3,536 patient-unique isolates, Acinetobacter baumannii imipenem susceptibility declined from 98.1 (1990) to 64.1% (2000), and ciprofloxacin susceptibility decreased from 50.5 to 13.1%. Imipenem median zone diameters decreased from 27.7 (1997) to 18.8 mm (2000). No outbreaks were detected. Two clusters were identified for 41 strains genotyped by pulsed-field gel electrophoresis, but imipenem resistance was not clonal.

Documentos Relacionados

• Investigation of carbapenemases and aminoglycoside modifying enzymes of Acinetobacter baumannii isolates recovered from patients admitted to intensive care units in a tertiary-care hospital in Brazil
• Assessing screening practices among health care workers at a tertiary-care hospital in Sao Paulo, Brazil
• Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital.
• Prevalence of Hepatitis C Virus Infection among Hemodialysis Patients at a Tertiary-Care Hospital in Mexico City, Mexico
• Prevalence and acquisition of MRSA amongst patients admitted to a tertiary-care hospital in brazil